Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer. Biomol Biomed [Internet]. 2021 Apr. 1 [cited 2024 May 4];21(2):198-207. Available from: https://bjbms.org/ojs/index.php/bjbms/article/view/4746